Jobs / United States / Pfizer INC
Rare Disease Hemophilia Account Specialist - South Florida
Pfizer INC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. • Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. • Disease education grounded in evidence: Reinforce evidence-based value narratives using approved materials to support informed clinical decision-making in hemophilia. • Coordinated care pathways & access: Partner across the matrix and with HTCs, specialty pharmacies, payers, and ancillary sites to simplify starts, reimbursement navigation, and continuity of care. Role Summary The Rare Disease – Hemophilia Account Specialist is a field-based specialty sales role responsible for driving the growth of the Hemophilia portfolio through compliant, strategic relationships within assigned accounts. This role partners with Hemophilia Treatment Centers (HTCs), Key Opinion Leaders (KOLs) and Hematologists to execute effective promotional strategies, support appropriate access, and deliver high-impact customer engagement. The Hemophilia Account Specialist leverages strong sales acumen, product and disease-state expertise, and a structured approach to in-person engagement while collaborating with cross-functional teams to achieve business objectives. Role Responsibilities • Drive customer engagement and sales performance through effective in-person interactions across Hemophilia Treatment Centers, HCPs, multidisciplinary HTC care teams and Community Hospitals. • Build strong, compliant relationships with hematologists, HTCs and multidisciplinary care teams across assigned accounts. • Deliver approved promotional and disease-state messaging to support appropriate Hemophilia product use. • Leverage product, disease, and market knowledge to identify opportunities, prioritize accounts, and support appropriate treatment options. • Support patient access by providing information on prior authorization requirements, reimbursement support, hubs, and co-pay resources as applicable. • Collaborate with cross-functional partners to address customer needs, remove access barriers, and advance Hemophilia business objectives. • Use digital tools and insights to plan, execute, and optimize Hemophilia territory activities. Basic Qualifications Education: Bachelor’s degree • OR an associate’s degree with 8+ years of work experience • OR a high school diploma (or equivalent) with 10+ years of wo